drugset / Trial / NCT00997152

Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

NCT00997152 ↗

Phase 2 Terminated 152 enrolled Akros Pharma Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of JTT-654 on diabetes as well as the safety, tolerability and pharmacokinetics of JTT-654 in type 2 diabetic patients.

Timeline

Start
2009-09
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject JTT-654 Unknown — —